Head-to-head reference

TB-500versusThymosin Beta-4

TB-500 and Thymosin Beta-4 are not the same molecule. Tβ4 is the full 43-amino-acid protein; TB-500 as sold is typically a short fragment. Research citations for one do not automatically transfer to the other.

Profile dataSide-by-side fieldsReviewed July 13, 2026

01Short answer

TB-500 and Thymosin Beta-4 are different compounds.

This guide compares the same profile fields for both. It does not decide which is better, recommend either compound, or determine whether switching or combining them is appropriate.

Specimen cards

Meet the two profiles

Field notes

Compare them side by side

Profile fieldATB-500BThymosin Beta-4

Overview

TB-500 (a thymosin beta-4 fragment) helps cells move, build new blood vessels, and calm inflammation so injured tissue (muscle, tendon, and wounds) can repair and regenerate more efficiently.

Thymosin Beta-4 is a 43-amino-acid peptide that your body naturally produces to orchestrate healing. It promotes blood vessel formation, reduces scarring (fibrosis), and protects tissues from damage. It's particularly valued for h...

Safety

Grade B · Good Safety

Generally well tolerated. Use with caution in cancer history.

Avoid in active cancers without medical supervision. May promote cell growth.

Grade B · Good Safety

Well-studied with good safety profile. Most side effects are mild and temporary.

Multiple fragments exist (Ac-SDKP, Tβ4(1-15), AGES). Caution in active cancer or peri-surgical periods. Avoid in mast-cell activation disorders.

Profile dosing context

2-5 mg per week, split into 2 injections

twice_weekly

4-8 weeks on, 4 weeks off

Can load with 6 mg first week then reduce; inject subcutaneously

300 mcg daily for 2 weeks (Ac-SDKP fragment)

daily

2 weeks on, 6 weeks off

Different fragments have different actions. Consult with provider on which is right for your goals

Requires titration

Occasional side effects

—

Injection site redness
Mild allergic reaction
Temporary fatigue

Reading the guide

Same fields. No invented certainty.

The comparison pulls from the live peptide profiles used across The Peptide App. Use it to spot differences in documented context, titration notes, and safety flags. Missing data remains missing rather than being inferred.

TB-500: Promotes new blood vessel growth and reduces inflammation for stubborn injuries.
Thymosin Beta-4: The full-length tissue repair peptide that TB-500 comes from

Questions people ask

Useful context, without a protocol.

What's the difference between TB-500 and Thymosin Beta-4?

TB-500 and Thymosin Beta-4 are distinct compounds and can differ in mechanism, documented profile context, titration notes, evidence, and safety flags. The comparison table shows the same stored fields side by side and leaves unavailable information blank.

Is TB-500 or Thymosin Beta-4 better?

There is no universal answer, and this page does not rank or recommend either compound. A licensed professional can interpret the evidence, product status, and individual context; this page is only a structured research comparison.

Can you take TB-500 and Thymosin Beta-4 together?

Combining peptides can change dosing complexity and risk. This comparison is not medical advice, and it should not be used to start, stop, or combine protocols. A licensed professional is the right person to evaluate whether any combination is appropriate.

This comparison is for research and educational purposes. It does not diagnose, treat, prescribe, or replace guidance from a licensed professional. Always follow the instructions provided with your product.

From research to routine

Track either protocol with less guesswork.

Keep dose timing, reminders, and protocol notes together in The Peptide App.

Open the app

Research context

Sources from the peptide profiles

Thymosin Beta-4 in Tissue Repair - Research Review

These references come from the TB-500 and Thymosin Beta-4 peptide profiles. Research cited for one compound does not automatically apply to the other.